Clinical Trials on Lymphoid Malignancies
Total 10692 results
-
R-PharmCompletedSolid MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced MalignanciesUnited States
-
Southwest Hospital, ChinaUnknown
-
Infinity Pharmaceuticals, Inc.Terminated
-
Mirati Therapeutics Inc.CompletedAdvanced MalignanciesUnited States
-
University of KentuckyArno TherapeuticsCompleted
-
Novartis PharmaceuticalsTerminatedAdvanced MalignanciesUnited States
-
Sigma-Tau Research, Inc.Dana-Farber Cancer Institute; Rhode Island HospitalCompletedSolid MalignanciesUnited States
-
Heidelberg Pharma AGUnited States Department of DefenseCompletedAdvanced MalignanciesUnited States
-
Massachusetts General HospitalTerminatedRefractory Lymphoma | Hematologic MalignancyUnited States
-
M.D. Anderson Cancer CenterRegeneron PharmaceuticalsNot yet recruitingSMARCB1-Deficient MalignanciesUnited States
-
TransThera Sciences (Nanjing), Inc.RecruitingB-Cell MalignanciesChina
-
Shenzhen Geno-Immune Medical InstituteRecruiting
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesJapan
-
AstraZenecaActive, not recruitingAdvanced Solid MalignanciesRomania, Moldova, Republic of
-
Sumitomo Pharma America, Inc.CompletedCancer, Advanced MalignanciesCanada, United States
-
Incyte CorporationCompleted
-
BeiGeneCompletedB-cell MalignanciesUnited States, Korea, Republic of, Australia, New Zealand, United Kingdom, Italy
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesNetherlands
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, France, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, United Kingdom
-
First Affiliated Hospital Xi'an Jiaotong UniversityEureka Therapeutics Inc.Unknown
-
Samyang Biopharmaceuticals CorporationCompleted
-
Washington University School of MedicineCompletedResistant Solid MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Gastrointestinal MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
Geron CorporationCompletedSolid Tumor MalignanciesUnited States
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Solid MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.WithdrawnAdvanced Nonhematologic MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesChina
-
Mayo ClinicGlaxoSmithKlineCompletedAdvanced Solid MalignanciesUnited States
-
AbbVieRoche-GenentechCompletedNon-Hodgkin's Lymphoma | Neuroblastoma | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | MalignanciesUnited States, Australia, Canada, France, Germany, Netherlands, Switzerland, United Kingdom
-
SynthekineRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | NHL | CLL/SLL | Large B-cell Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
Sanjay MohanAbbVie; Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
Colorado Blood Cancer InstituteUnknownAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Chronic Myeloid LeukemiaUnited States
-
Roswell Park Cancer InstituteRecruitingRecurrent Mantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Mantle Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell... and other conditionsUnited States
-
IDP Discovery Pharma S.L.RecruitingChronic Lymphocytic Leukemia (CLL) | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Multiple Myeloma (MM) | High Grade B-Cell Lymphoma, Not Otherwise Specified | Double Hit Lymphoma | Triple Hit LymphomaSpain
-
University of California, San FranciscoTerminatedAcute Myeloid Leukemia | Multiple Myeloma | Hodgkin Disease | Lymphoma, Mantle-Cell | Acute Lymphoblastic Leukemia | Lymphoma, T-Cell, Peripheral | Chronic Myelogenous Leukemia | Myelodysplasia | Lymphoma, Large-Cell, Diffuse | T-NK Cell LymphomaUnited States
-
Medical College of WisconsinCompletedMalignancies, HematologicUnited States
-
Shanghai Tongji Hospital, Tongji University School...Recruiting
-
University of PittsburghAmerican College of Radiation OncologyNot yet recruitingUpper Abdominal MalignanciesUnited States
-
Shenzhen Geno-Immune Medical InstituteRecruiting
-
Shenzhen Geno-Immune Medical InstituteRecruiting
-
Athenex, Inc.RecruitingAdvanced Solid MalignanciesUnited States
-
Novartis PharmaceuticalsRecruitingALK Positive MalignanciesGermany, France, Australia, Belgium, Italy, Korea, Republic of, Poland, China, United States, Taiwan, Brazil, Bulgaria, Hong Kong, Japan, Lebanon, Malaysia, Spain, Russian Federation, Colombia, Singapore, Czechia
-
Incyte CorporationActive, not recruitingB-cell MalignanciesUnited States
-
Carrick Therapeutics LimitedCompletedAdvanced Solid MalignanciesUnited States, United Kingdom
-
Gilead SciencesActive, not recruitingB-cell MalignanciesUnited States, United Kingdom, France
-
BeiGeneCompletedB-cell MalignanciesAustralia
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesFrance, Spain, Canada